Integrated BioPharma, Inc. (INBP)
| Market Cap | 28.21M |
| Revenue (ttm) | 56.60M |
| Net Income (ttm) | 5.10M |
| Shares Out | 29.65M |
| EPS (ttm) | 0.16 |
| PE Ratio | 5.97 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | February 26 |
| Last Price | $0.9500 |
| Previous Close | $0.9600 |
| Change ($) | -0.0100 |
| Change (%) | -1.04% |
| Day's Open | 0.9200 |
| Day's Range | 0.9200 - 0.9500 |
| Day's Volume | 5,700 |
| 52-Week Range | 0.23 - 1.09 |
News
NEW YORK, Jan. 22, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced Integrated BioPharma, Inc. (O...
The company's quarterly results saw revenue increase 33% and earnings increase 233% to $0.04 per share. With a current share price of about $0.60, the stock is trading for under 4x trailing ea...
About INBP
Integrated BioPharma, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through two segments, Contract Manufacturing and Other Nutraceutical Businesses. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment distributes healthful nutritiona... [Read more...]
| Industry Packaged Foods | IPO Date Oct 29, 1996 |
| Stock Exchange OTCMKTS | Ticker Symbol INBP |
Financial Performance
In 2020, INBP's revenue was $52.77 million, an increase of 5.59% compared to the previous year's $49.98 million. Earnings were $4.11 million, an increase of 143.36%.